Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
Identifiers
Identifiers
Date issued
2014Journal title
Arthritis and Rheumatology
Type of content
Artigo